
Health minister Mark Butler confirms Ocrevus, Kesimpta and Lemtrada will stay subsidised amid questions about the Pharmaceutical Benefits Scheme Get our breaking news email , free app or daily news podcast Australians living with multiple…
View original source — The Guardian ↗

